Renalytix (LON:RENX) Shares Down 0.1% – Here’s What Happened

Renalytix Plc (LON:RENX – Get Free Report) shares traded down 0.1% on Monday . The company traded as low as GBX 6.63 and last traded at GBX 6.73. 460,119 shares traded hands during mid-day trading, a decline of 69% from the average session volume of 1,490,314 shares. The stock had previously closed at GBX 6.74.

Renalytix Stock Down 0.1%

The company has a debt-to-equity ratio of -72.91, a quick ratio of 2.42 and a current ratio of 0.24. The stock’s 50 day moving average price is GBX 7.77 and its 200-day moving average price is GBX 7.34. The company has a market cap of £29.41 million, a PE ratio of -0.96 and a beta of 2.10.

Renalytix Company Profile

(Get Free Report)

Renalytix (LSE: RENX) (NASDAQ: RNLX) is a developer of artificial intelligence-enabled clinical in vitro diagnostic solutions for kidney disease, one of the most common and costly chronic medical conditions globally. The Company’s lead product is KidneyIntelX, which has been granted Breakthrough Designation by the U.S.

See Also

• Five stocks we like better than Renalytix
• About the Markup Calculator
• What Dollar Tree’s Surge and Home Depot’s Slide Say About Consumer Health
• The Most Important Warren Buffett Stock for Investors: His Own
• 3 Stocks Most Likely to Split in 2026
• What is Forex and How Does it Work?
• ChargePoint’s Comeback Story: Why This EV Stock Is Charging Up Again